Travere Therapeutics logo
Healthcare & Life Sciences

Travere Therapeutics

San Diego, United Statestravere.com/

Travere Therapeutics is a Healthcare & Life Sciences startup based in San Diego, the United States, since gone public, 2 tracked investors.

Activeipo
ipo
Stage
2018
Founded
2
Investors

About Travere Therapeutics

Based in San Diego, the United States, Travere Therapeutics is a startup founded in 2018. Its most recent tracked round is IPO. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Travere Therapeutics is a biopharmaceutical company that develops and commercializes therapies for rare kidney diseases including Focal Segmental Glomerulosclerosis (FSGS), IgA Nephropathy (IgAN), Classical Homocystinuria (HCU), and Cystinuria.

Explore Travere Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States